ClassID:

97012

C07K14/655 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Hormones Somatostatins

Sub-classes:
Recent Application in this class:
#1
20250276018
2025-09-04

CAR CONSTRUCTS AND METHODS OF TREATMENT

#2
20250154219
2025-05-15

PEPTIDE ANALOGS

#3
20250121035
2025-04-17

CONTROLLED RELEASE PEPTIDE FORMULATIONS

#4
20240383959
2024-11-21

CELL-FREE METHODS AND COMPOSITIONS COMPRISING TAGLESS THERAPEUTIC HORMONES

#5
20230416331
2023-12-28

PEPTIDE CONJUGATES OF PEPTIDIC TUBULIN INHIBITORS AS THERAPEUTICS

#6
20230287598
2023-09-14

HUMANIZED ANTIBODIES WITH ULTRALONG COMPLEMENTARY DETERMINING REGIONS

#7
20220324935
2022-10-13

Peptide analogs

#8
20220235112
2022-07-28

GBD-SSTad-SSTad recombinant protein and method for producing and using same

#9
20220162284
2022-05-26

Synthetic somatostatin receptor ligands

#10
20220135640
2022-05-05

CORTISTATIN OR AN ANALOGUE THEREOF AS A PHARMACEUTICALLY ACTIVE AGENT IN LATENT FORM

#11
20220047679
2022-02-17

COMBINATION THERAPY

#12
20220041649
2022-02-10

Methods for Synthesis of Radionuclide Complex

#13
20210317161
2021-10-14

A PROCESS FOR THE PREPARATION OF PASIREOTIDE

#14
20200339649
2020-10-29

Peptide analogs

#15
20200325203
2020-10-15

Synthetic somatostatin receptor ligands

#16
20200239599
2020-07-30

Humanized antibodies with ultralong complementary determining regions

#17
20200131224
2020-04-30

Methods for Synthesis of Radionuclide Complex

#18
20200108150
2020-04-09

Reversible covalent linkage of functional molecules

#19
20190374634
2019-12-12

Methods for improving immunological response in vaccinated animals

#20
20190359676
2019-11-28

Heparin-binding domain of IGFBP-2 in the treatment of metabolic disorders

#21
20190352365
2019-11-21

EXPRESSION CONSTRUCT AND METHOD FOR PRODUCING PROTEINS OF INTEREST

#22
20190276513
2019-09-12

Synthetic somatostatin receptor ligands

#23
20190142950
2019-05-16

Reversible covalent linkage of functional molecules

#24
20190106473
2019-04-11

Conjugates, their compositions, their uses, and their methods of making

#25
20180313820
2018-11-01

STABILIZED BIOACTIVE PEPTIDES AND METHODS OF IDENTIFICATION, SYNTHESIS, AND USE

#26
20180264129
2018-09-20

Core constructs and their uses in configuring pharmaceutical molecules

#27
20180187232
2018-07-05

EFFICIENT PRODUCTION OF PEPTIDES

#28
20170298113
2017-10-19

Synthetic somatostatin receptor ligands

#29
20170157260
2017-06-08

Glycosylated polypeptide and drug composition containing said polypeptide

#30
20170137489
2017-05-18

Process for the Synthesis of Therapeutic Peptides

#31
20170074858
2017-03-16

Stabilizied bioactive peptides and methods of identification, synthesis and use

#32
20170056518
2017-03-02

Pharmaceuticals in joint-linker configurations for treating pathological blood clots

#33
20170020951
2017-01-26

Neuropeptide analogs, compositions, and methods for treating pain

#34
20160368961
2016-12-22

Glycosylated polypeptide and drug composition containing said polypeptide

#35
20160333068
2016-11-17

Compositions and methods for imaging cancer

#36
20160208021
2016-07-21

Molecular constructs with targeting and effector moieties

#37
20160208020
2016-07-21

Peptide core-based multi-arm linkers

#38
20160206754
2016-07-21

Molecular constructs for treating tumors

#39
20160185822
2016-06-30

Cortistatin analogues for the treatment of inflammatory and/or immune diseases

#40
20160176942
2016-06-23

Reversible covalent linkage of functional molecules

#41
20160159928
2016-06-09

Humanized antibodies with ultralong complementary determining regions

#42
20160051668
2016-02-25

Methods for improving immunological response in vaccinated animals

#43
20150329619
2015-11-19

Albumin fusion proteins

#44
20150290330
2015-10-15

Somatostatin-dopamine chimeric analogs

#45
20150203568
2015-07-23

Albumin fusion proteins

#46
20150148522
2015-05-28

Somatostatin-dopamine chimeric analogs

#47
20150045534
2015-02-12

Process for the synthesis of therapeutic peptides

#48
20150017685
2015-01-15

Efficient production of peptides

#49
20140336116
2014-11-13

Glycosylated polypeptide and drug composition containing said polypeptide

#50
20140162944
2014-06-12

Controlled release peptide formulations

#51
20140121354
2014-05-01

Somatostatin-dopamine chimeric analogs

#52
20130324467
2013-12-05

NEUROPEPTIDE ANALOGS, COMPOSITIONS, AND METHODS FOR TREATING PAIN

#53
20130252892
2013-09-26

Octapeptide compounds and therapeutic use thereof

#54
20130237480
2013-09-12

Combinations of somatostatin-analogs with different selectivity for human somatostatin receptor subtypes

#55
20120190814
2012-07-26

Thiol Protecting Group

#56
20120190579
2012-07-26

Functionalisation of Solid Substrates

#57
20120190124
2012-07-26

Reversible covalent linkage of functional molecules

#58
20120177571
2012-07-12

PANCREATIC ENDOCRINE CELL INDICATING AGENT AND UTILIZATION OF SAME

#59
20120149803
2012-06-14

Autoxidisable aqueous coating compositions

#60
20120149640
2012-06-14

Peptides and uses thereof to modulate IGF-1 synthesis and IGF-1 receptor expression

#61
20120122781
2012-05-17

Peptide ligands of somatostatin receptors

#62
20120076806
2012-03-29

Chloramphenicol acetyl transferase (CAT)-defective somatostatin fusion protein and uses thereof

#63
20120059145
2012-03-08

Stabilized bioactive peptides and methods of identification, synthesis, and use

#64
20120046221
2012-02-23

Albumin fusion proteins

#65
20110269683
2011-11-03

Receptor(SSTR2)-selective somatostatin antagonists

#66
20110237774
2011-09-29

METHOD FOR INTRODUCING DOTA

#67
20110195080
2011-08-11

Methods for enhanced somatostatin immunogenicity in the treatment of obesity

#68
20110172157
2011-07-14

Somatostatin analogues

#69
20110166320
2011-07-07

Somatostatin analogues

#70
20110112990
2011-05-12

Efficient production of peptides

#71
20110009312
2011-01-13

Albumin fusion proteins

#72
20100323964
2010-12-23

Non-selective somatostatin analogues

#73
20100240865
2010-09-23

PROCESS FOR PRODUCTION OF CYCLIC PEPTIDES

#74
20100137559
2010-06-03

PROCESS FOR PRODUCTION OF CYCLIC PEPTIDES

#75
20100136037
2010-06-03

Chloramphenicol acetyl transferase (CAT)-defective somatostatin fusion protein and uses thereof

#76
20100113367
2010-05-06

Peptide-cytotoxic conjugates

#77
20100016653
2010-01-21

Quantitative Trait Loci and Somatostatin

#78
20090324629
2009-12-31

Chloramphenicol acetyl transferase (CAT)-defective somatostatin fusion protein and uses thereof

#79
20090317326
2009-12-24

RADIOFLUORINATION METHODS

#80
20090099073
2009-04-16

Albumin Fusion Proteins

#81
20090093402
2009-04-09

Albumin Fusion Proteins

#82
20090093023
2009-04-09

Elements for improved expression of bovine somatotropin

#83
20090069225
2009-03-12

Somatostatin analogues

#84
20090029910
2009-01-29

Combinations of somatostatin-analogs with different selectivity for human somatostatin receptor subtypes

#85
20090018081
2009-01-15

ACTIVATABLE CLOSTRIDIAL TOXINS

#86
20090004696
2009-01-01

Stabilized bioactive peptides and methods of identification, synthesis, and use

#87
20080299040
2008-12-04

Somatostatin receptor 2 antagonists

#88
20080261880
2008-10-23

Synthetic approach to designed chemical structures

#89
20080260638
2008-10-23

Receptor(SSTR2)-selective somatostatin antagonists

#90
20080213886
2008-09-04

Albumin fusion proteins

#91
20080171853
2008-07-17

Somatostatin antagonists

#92
20080167240
2008-07-10

Albumin Fusion Proteins

#93
20080167239
2008-07-10

Albumin fusion proteins comprising insulin polypeptides

#94
20080161243
2008-07-03

Albumin Fusion Proteins

#95
20080153751
2008-06-26

G-CSF-albumin fusion proteins

#96
20080146503
2008-06-19

Albumin fusion proteins

#97
20080020970
2008-01-24

Somatostatin antagonists

#98
20080008655
2008-01-10

Tumor-targeted optical contrast agents

#99
20070259815
2007-11-08

Albumin fusion proteins

#100
20070244047
2007-10-18

Albumin fusion proteins

#101
20070154392
2007-07-05

Treatment process using somatostatin analogues

#102
20070106064
2007-05-10

Solid phase method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same

#103
20070093645
2007-04-26

Peptide vectors

#104
20070077195
2007-04-05

N and/or N derivatized, metal and organic protected L-histidine for coupling to biomolecules for highly efficient labeling with [M(OH)(CO)] by coordination

#105
20060276626
2006-12-07

Methods for the production of peptide derivatives

#106
20060276396
2006-12-07

Albumin fusion proteins

#107
20060194735
2006-08-31

Albumin fusion proteins

#108
20060183191
2006-08-17

Synthetic approach to designed chemical structures

#109
20060099571
2006-05-11

Stabilized bioactive peptides and methods of identification, synthesis, and use

#110
20060036072
2006-02-16

Short-warp peptide-dye conjugate as contrast agent for optical diagnostic

#111
20050245438
2005-11-03

Receptor(SSTR4)-selective somatostatin analogs

#112
20050226813
2005-10-13

Labelled somatostatin analogs backbone cyclized through metal complexation

#113
20050186664
2005-08-25

Albumin fusion proteins comprising GLP-1 polypeptides

#114
20050014686
2005-01-20

Somatostatin analogues

#115
20050008573
2005-01-13

Peptides conjugates, their derivatives with metal complexes and use thereof for magnetic resonance imaging (mri)